![Alan Montgomery](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alan Montgomery
Director/Board Member at XENCOR, INC.
Net worth: 261 194 $ as of 30/05/2024
Network origin in Alan Montgomery first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Biotechnology | 47 | |
29
| Public Company | Biotechnology | 29 |
Subsidiary | Pharmaceuticals: Major | 25 | |
ZymoGenetics, Inc.
![]() ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.
17
| Extinct | Pharmaceuticals: Major | 17 |
W Fund Management LLC
![]() W Fund Management LLC Investment ManagersFinance W Fund Management LLC (W Fund) is a venture capital firm founded in 2012 by Mr. Hamburg Robert. The firm is headquartered in Seattle, Washington.
16
| Private Company | Investment Managers | 16 |
Corus Pharma, Inc.
![]() Corus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Corus Pharma, Inc. develops drugs to treat needs in infectious diseases and respiratory areas. The firm's core competencies reside in the identification of drugs, rapid clinical development, and FDA approval of its products. The firm was founded in January 2001 by A. Bruce Montgomery and is headquartered in Seattle, WA.
11
| Extinct | Pharmaceuticals: Major | 11 |
PathoGenesis Corp
![]() PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million.
7
| Subsidiary | Biotechnology | 7 |
Avalyn Pharma, Inc.
![]() Avalyn Pharma, Inc. Pharmaceuticals: MajorHealth Technology Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Vicis LLC
![]() Vicis LLC Recreational ProductsConsumer Durables Vicis LLC designs and manufactures football helmets that mitigate linear and rotational impact forces. The company was founded by Samuel R. Browd, David L. Marver, Jonathan Posner and Per Reinhall in 2013 and is headquartered in Seattle, WA.
5
| Holding Company | Recreational Products | 5 |
Public Company | Pharmaceuticals: Major | 4 | |
Cardeas Pharma Corp.
![]() Cardeas Pharma Corp. Pharmaceuticals: MajorHealth Technology Cardeas Pharma Corp. develops drugs for the prevention of ventilator associated pneumonia. It offers a novel antibiotic formulation of two drugs with synergistic activity against relevant, resistant Gram-negative bacilli, including pseudomonas aeruginosa, acinetobacter baumannii, and carbapenem-resistant Enterobacteriaceae. The company was founded by Alan Bruce Montgomery on November 23, 2011 and is headquartered in Seattle, WA.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Alan Montgomery via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Masters Business Admin Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
Stanford University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree Graduate Degree Masters Business Admin | |
Accelerator Services Corp
![]() Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Consultant / Advisor Consultant / Advisor Consultant / Advisor Private Equity Investor Private Equity Investor | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of California, Berkeley | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
University of California, Los Angeles | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree | |
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
University of Oxford | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Medarex, Inc.
![]() Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | President Director/Board Member Corporate Officer/Principal | |
University of California San Diego | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
The Johns Hopkins University | College/University | Graduate Degree Doctorate Degree Undergraduate Degree | |
Immunex Corp.
![]() Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Chief Executive Officer Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
University of Michigan | College/University | Corporate Officer/Principal Graduate Degree Graduate Degree | |
Madrona Venture Group LLC
![]() Madrona Venture Group LLC Investment ManagersFinance Madrona Venture Group LLC (Madrona Venture Group) is a venture capital firm founded in 1995 by Tom A. Alberg, Paul B. Goodrich and Jerry Grinstein. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Chief Operating Officer Private Equity Investor | |
University of Illinois | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
The Pennsylvania State University | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree | |
Yale University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Deloitte & Touche LLP
![]() Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Pivotal Bioventure Partners Investment Advisor LLC
![]() Pivotal Bioventure Partners Investment Advisor LLC Investment ManagersFinance Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California. | Investment Managers | Consultant / Advisor Private Equity Investor Private Equity Analyst | |
ENANTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
University of Arizona | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree | |
University of California, Davis | College/University | Doctorate Degree Doctorate Degree | |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Bay City Capital LLC
![]() Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal | |
Genesis Research & Development Corp. Ltd.
![]() Genesis Research & Development Corp. Ltd. Financial ConglomeratesFinance Genesis Research & Development Corp. Ltd. operates as a development stage company. Previously, it was a technology investment company that builds a broad therapeutic development platform targeting immune disorders and cancer and a novel single stranded gene silencing technology using the RNAi mechanism. The company was founded by James Douglas Watson in 1994 and is headquartered in Auckland, New Zealand. | Financial Conglomerates | Director/Board Member Corporate Officer/Principal | |
DERMIRA, INC. | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
University of California | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
WRF Capital
![]() WRF Capital Investment ManagersFinance WRF Capital (WRF Capital) is a venture capital firm founded in 1994 by Ronald Howell. The firm is headquartered in Seattle, Washington. | Investment Managers | Chief Executive Officer Private Equity Investor | |
ARCH Venture Partners LLC
![]() ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Investor Corporate Officer/Principal | |
Acylin Therapeutics, Inc.
![]() Acylin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acylin Therapeutics, Inc. develops drugs for cancer. The company was founded by Philip A. Cole, Peter S. DiStefano, Ronen Marmorstein, Suresh K. Jain and Roydon Price in 2009 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Kenyon College | College/University | Director/Board Member Undergraduate Degree | |
NS WIND DOWN CO., INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Stanford University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
INTERMUNE INC | Biotechnology | Corporate Officer/Principal General Counsel | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ASSEMBLY BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
Novartis Institutes for Biomedical Research, Inc.
![]() Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Tech/Sci/R&D Officer |
Statistics
International
United States | 49 |
United Kingdom | 2 |
New Zealand | 2 |
Sectoral
Health Technology | 21 |
Consumer Services | 18 |
Finance | 8 |
Commercial Services | 6 |
Electronic Technology | 2 |
Operational
Director/Board Member | 535 |
Corporate Officer/Principal | 223 |
Independent Dir/Board Member | 145 |
Chairman | 91 |
Undergraduate Degree | 88 |
Most connected contacts
Insiders | |
---|---|
Steven Gillis | 58 |
Chad Waite | 39 |
Jonathan Fleming | 36 |
Robin Washington | 34 |
Heather Elizabeth Preston | 34 |
Deepa Pakianathan | 32 |
Patrick Ennis | 30 |
Peter Bisgaard | 28 |
Bruce Carter | 25 |
Douglas Williams | 25 |
Per Wold-Olsen | 25 |
Robert F. Baltera | 23 |
Stephen M. Dow | 20 |
Wendy Yarno | 19 |
Richard Whitley | 18 |
- Stock Market
- Insiders
- Alan Montgomery
- Company connections